Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 308-318

  Marinho, Claudio R F ^a   D'Império Lima, Maria Regina ^a   Grisotto, Marcos G ^a   Alvarez, José M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNE SYSTEM; LIFESPAN; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITEMIA; PARASITOSIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

EID: 0344286486     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.308-318.1999     Document Type: Article

References (49)

1. Abrahamsohn, I. A., and R. L. Coffman. 1996. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84:231-244.
2. Aliberti, J. C., M. A. Cardoso, G. A. Martins, R. T. Gazzinelli, L. Y. Vieira, and J. S. Silva. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1961-1967.
3. Alvarez, J. M., A. Oshima, V. Mozer, and L. Guimarāes. 1991. Evolution of subpatent parasitaemia in Trypanosoma cruzi chronically infected mice with the help of a cyclophosphamide amplification transfer assay. Rev. Inst. Med. Trop. São Paulo 33:509-514.
4. Avrameas, S., T. Ternynck, and J. L. Guesdon. 1979. Coupling of enzymes to antibodies and antigens. Scand. J. Immunol. 8:7-23.
5. Birkeland, M. L., P. Johnson, I. S. Trowbridge, and E. Puré. 1989. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc. Natl. Acad. Sci. USA 86:6734-6738.
6. Bottomly, K., M. Luqman, L. Greenbaum, S. Carding, J. West, T. Pasqualini, and D. B. Murphy. 1989. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur. J. Immunol. 19:617-623.
7. Cunha-Neto, E., M. Duranti, A. Gruber, B. Zingales, I. De Messias, N. Stolf, G. Bellotti, M. E. Patarroyo, F. Pilleggi, and J. Kalil. 1995. Autoimmunity in Chagas disease cardiopathy: biological relevance of a myosin-specific epitope cross-reactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. USA 92:3541-3545.
8. Curotto de Lafaille, M. A., L. C. Barbosa de Oliveira, G. C. Lima, and I. Abrahamsohn. 1990. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp. Parasitol. 70:164-174.
9. Czerkinsky, C. C., L. A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
10. D'Império Lima, M. R., H. Eisen, P. Minóprio, M. Joskowicz, and A. Coutinho. 1986. Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas' disease. J. Immunol. 137:353-357.
11. D'Império Lima, M. R., M. Joskowicz, A. Coutinho, T. Kipnis, and H. Eisen. 1985. Very large and isotypically atypical polyclonal plaque forming cell responses in mice infected with Trypanosoma cruzi. Eur. J. Immunol. 15:201-203.
12. Ferreira, M. U., E. A. S. Kimura, J. M. Souza, and A. M. Katzin. 1996. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients. Am. J. Trop. Med. Hyg. 55:315-323.
13. Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22:2501-2506.
14. Harel-Bellan, A. M., M. Joskowicz, D. Fradelizi, and H. Eisen. 1983. Modification of T cell proliferation and interleukin-2 production in mice infected with Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 80:3466-3469.
15. Higuchi, M., T. De Brito, M. M. Reis, A. Barbosa, G. Bellotti, A. C. Pereira-Barreto, and F. Pileggi. 1993. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Card. Pathol. 2:101-106.
16. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316.
17. Jones, E. M., D. G. Colley, S. Tostes, E. Reis Lopes, C. L. Vnencak-Jones, and T. L. McCurley. 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:348-357.
18. Krettli, A. U., and Z. Brenner. 1976. Protective effects of specific antibodies in Trypanosoma cruzi infection. J. Immunol. 116:755-760.
19. Kühn, R., J. Löhler, D. Rennick, K. Rajewski, and W. Müller. 1993. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75:203-274.
20. + T cells. J. Immunol. 144:3288-3295.
21. Llop, F., F. Rothhammer, M. Acuna, and W. Apt. 1988. HLA antigens in cardiomyopathic Chilean chagasics. Am. J. Hum. Genet. 43:770-773.
22. Minóprio, P., A. Bandeira, P. Pereira, T. A. Mota-Santos, and A. Coutinho. 1989. Preferential expansion of Ly1-B and CD4-CD8-T cells in the polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. Int. Immunol. 1:176-184.
23. Minóprio, P., L. Andrade, M. P. Lembezat, L. S. Ozaki, and A. Coutinho. 1989. Indiscriminate representation of VH-gene families in the murine B lymphocyte responses to Trypanosoma cruzi. J. Immunol. 142:4017-4021.
24. Moncayo, A. 1993. Maladie de Chagas. WHO/TDR Program Rep. 11:67.
25. Mosmann, T. R., and K. W. M. Moore. 1991. The role of 1L-10 in cross-regulation of Th1 and Th2 responses. Immunol. Today 12:49-53.
26. + T cells. Immunol. Rev. 123:209-229.
27. Muñoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:301-307.
28. Olivares-Fontt, E., K. Heirman, K. Thielemans, and B. Vray. 1996. Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect. Immun. 64:3429-3434.
29. Petray, P. B., M. E. Rottemberg, G. Bertot, R. S. Corral, A. Diaz, A. Örn, and S. Gristein. 1993. Effect of anti-γ-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunol. Lett. 35:77-80.
30. Postan, M., J. J. Bailey, J. A. Dvorak, J. P. McDaniel, and E. W. Pottala. 1987. Studies of Trypanosoma cruzi clones in inbred mice. III. Histopathological and electrocardiographical responses to chronic infection. Am. J. Trop. Med. Hyg. 37:541-549.
31. Low subset. J. Exp. Med. 172:1701-1708.
32. Low cells are important for the balance between protective and pathologic cell-mediated immunity. J. Exp. Med. 179:589-600.
33. Rodriguez, A. M., F. Santoro, D. Afchain, H. Bazin, and A. Capron. 1981. Trypanosoma cruzi infection in B-cell-deficient rats. Infect. Immun. 31:524-529.
34. Rottemberg, M. E., A. Riarte, L. Sporrong, J. Alcheh, P. Petray, A. M. Ruiz, H. Wigzell, and A. Orn. 1995. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol. Lett. 45:53-60.
35. Russo, M., N. Starobinas, P. Minóprio, A. Coutinho, and M. Hontebeyrie-Joskowicz. 1988. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after activation of helper T cells. Ann. Inst. Pasteur Immunol. 139:225-236.
36. Sadigursky, M., A. M. Acosta, and C. A. Santos-Busch. 1982. Muscle sarcoplasmic reticulum antigen shared by a Trypanosoma cruzi clone. Am. Soc. Trop. Med. Hyg. 31:934-941.
37. Santos-Lima, E. C., I. Gracia, M. H. Vicentelli, P. Vassalli, and P. Minóprio. 1997. Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect. Immun. 65:457-465.
38. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301-309.
39. Segura, M. A., E. Moline de Raspi, and M. A. Basombrio. 1994. Reversibility of muscle and heart lesions in chronic T. cruzi infected mice after late trypanocidal treatment. Mem. Inst. Oswaldo Cruz 89:213-216.
40. Silva, J. S., D. R. Twardzik, and S. J. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF beta). J. Exp. Med. 174:539-545.
41. + cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717-724.
42. Tarleton, R. L. 1993. Pathology of American trypanosomiasis, p. 64-71. In K. S. Warren (ed.), Immunology and molecular biology of parasitic infections, 3rd ed. Blackwell Scientific Publications, Boston, Mass.
43. Tarleton, R. L., B. H. Koller, A. Latour, and M. Postan. 1992. Susceptibility of β2 microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:338-340.
44. Tarleton, R. L., L. Zhang, and M. O. Downs. 1997. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA 94:3932-3937.
45. Torrico, F., H. Heremans, M. T. Rivera, E. Van Marck, A. Billiau, and Y. Carlier. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:3626-3632.
46. Vago, A. R., A. M. Macedo, S. J. Adad, D. D'Avila Reis, and R. Correia de Oliveira. 1996. PCR detection of Trypanosoma cruzi DNA in oesophageal tissue of patients with chronic digestive Chagas' disease. Lancet 348:891-892.
47. Van Voorhis, W. C., and H. Eisen. 1989. FL160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J. Exp. Med. 169:641-652.
48. Viotti, R., C. Vigliano, H. Armeti, and E. Segura. 1994. Treatment of chronic Chagas' disease with benzonidazole: clinical and serological evolution of patients with long-term follow-up. Am. Heart J. 127:151-162.
49. Zhang, L., and R. L. Tarleton. 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26:102-109.